Combivir
Product Images NDC 52959-546

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Combivir (NDC 52959-546). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by H.j. Harkins Company, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Lamivudine Chemical Structure (8fada68f F4a9 4359 Ba7d D66c835da3a5 01)

FDA Label Image

Zidovudine Chemical Structure (8fada68f F4a9 4359 Ba7d D66c835da3a5 02)

FDA Label Image

Combivir Label (8fada68f F4a9 4359 Ba7d D66c835da3a5 03)

Combivir Label (8fada68f F4a9 4359 Ba7d D66c835da3a5 03)
This text appears to be a medication label for Comblivir 150/300mg Tablet manufactured by GlaxoSmithKline and with lot number CMB49GK. There are instructions to take the medication as directed by a doctor and to refer to the package insert for dosage information. The pill is described as white and oval. There is also a second lot number mentioned, CMBASGK, and a reference to a drug called Zidovudine.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.